Categories: aggregated

New THC-CBD Pill for MS and Huntington’s Disease May Be First to Benefit from Biden’s New Marijuana Research Bill

In related news, President Biden signed the Marijuana Research and Expansion Act into law. This will speed up researchers’ bids for DEA schedule 1 registration authorization to undertake these trials. After seven hard years of waiting, the MMJ group of firms can finish their mission of performing clinical studies on Huntington’s Disease and Multiple Sclerosis. MMJ has received FDA Orphan Designation for its Huntington’s disease clinical trials.

Jason

Share
Published by
Jason

Recent Posts

Why Does Cannabis Make Exercise So Much More Rewarding?

As we wrap up our deep dive into cannabis and exercise, I can't help but…

1 hour ago

LA’s cannabis community steps up for wildfire relief

Follow our links to verified aid groups. The post LA’s cannabis community steps up for…

3 days ago

America’s Constitutional Conundrum: Guns and Ganja

As you might imagine, telling Americans they can't have their guns AND their ganja isn't…

3 days ago

Meet the new and improved home of the growers, ILGM

The new ILGM is a veritable treasure trove of expert knowledge that’ll help you find…

4 days ago

No Smoking, No Vaping – What’s the Safest Way to Consume Cannabis Based on Your Genetics and Science?

edibles, tinctures, beverages, and cannabis oil to name a few. Now, the results of a…

4 days ago